Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Neuromuscular Junction And Blockade01:29

Neuromuscular Junction And Blockade

3.9K
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
3.9K
The Neuromuscular Junction01:19

The Neuromuscular Junction

15.0K
The nervous system consists of complex motor neuron circuits, including upper motor neurons originating from the cerebral cortex and lower motor neurons starting in the spinal cord, coordinating both voluntary and involuntary movements. Among these, somatic motor neurons activate skeletal muscles and are classified into alpha, beta, and gamma types. Alpha neurons are vital for voluntary movement coordination, while gamma neurons adjust muscle spindle sensitivity, and the function of beta...
15.0K
Muscle Coordination and Action01:24

Muscle Coordination and Action

2.4K
Muscle coordination is a complex and finely tuned process essential for smooth and purposeful movements like flexion, extension, adduction, abduction, and rotation. The human body orchestrates the actions of various muscles working in concert, each with a specific role. Four functional types describe how muscles work together: agonist, antagonist, synergist, and fixator.
Agonists
Agonist muscles, often called prime movers, are the primary muscles responsible for producing a specific movement....
2.4K
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

4.0K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
4.0K
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action01:17

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

2.3K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
2.3K
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

9.8K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
9.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A myoneural actuator with engineered biophysics for implantable biohybrid systems.

Nature communications·2026
Same author

Design and evaluation of a bone-anchored, neurally-controlled knee prosthesis.

Journal of neuroengineering and rehabilitation·2026
Same author

Human Implementation of Upper Extremity Amputation Incorporating Agonist-Antagonist Myoneural Interface Construction.

Plastic and reconstructive surgery·2025
Same author

Continuous neural control of a 2-DOF ankle-foot prosthesis enables dynamic obstacle maneuvers after transtibial amputation.

medRxiv : the preprint server for health sciences·2025
Same author

Functional Outcomes of Individuals Undergoing the Ewing Amputation.

Archives of physical medicine and rehabilitation·2025
Same author

MRI Safety Considerations for Permanent Magnet Implants in Muscle.

Journal of magnetic resonance imaging : JMRI·2025
Same journal

Bionic Reconstruction of the Upper Extremity.

Hand clinics·2026
Same journal

Erratum.

Hand clinics·2026
Same journal

Occupational Therapist Perspectives in Upper Limb Prosthetic Rehabilitation.

Hand clinics·2026
Same journal

Mental Health: The Invisible Challenge and the Opportunity.

Hand clinics·2026
Same journal

The Role of Amputation and Myoelectric Prosthetic Fitting in Traumatic Adult Brachial Plexus Injury.

Hand clinics·2026
Same journal

Osseointegration of the Upper Extremity.

Hand clinics·2026
See all related articles

Related Experiment Video

Updated: Oct 29, 2025

The Muscle Cuff Regenerative Peripheral Nerve Interface for the Amplification of Intact Peripheral Nerve Signals
07:30

The Muscle Cuff Regenerative Peripheral Nerve Interface for the Amplification of Intact Peripheral Nerve Signals

Published on: January 13, 2022

2.2K

The Agonist-Antagonist Myoneural Interface.

Matthew J Carty1, Hugh M Herr2

  • 1Division of Plastic Surgery, Brigham and Women's Hospital, Boston, MA, USA.

Hand Clinics
|July 13, 2021
PubMed
Summary
This summary is machine-generated.

A new agonist-antagonist myoneural interface improves prosthetic control and preserves limb function after amputation. This approach enhances volitional control, maintains proprioception, and prevents muscle atrophy.

Keywords:
Agonist-antagonist myoneural interfaceAmputationProprioceptionProstheses

More Related Videos

Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction
11:07

Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction

Published on: April 14, 2022

2.6K
Fabrication of the Composite Regenerative Peripheral Nerve Interface C-RPNI in the Adult Rat
10:35

Fabrication of the Composite Regenerative Peripheral Nerve Interface C-RPNI in the Adult Rat

Published on: February 25, 2020

8.5K

Related Experiment Videos

Last Updated: Oct 29, 2025

The Muscle Cuff Regenerative Peripheral Nerve Interface for the Amplification of Intact Peripheral Nerve Signals
07:30

The Muscle Cuff Regenerative Peripheral Nerve Interface for the Amplification of Intact Peripheral Nerve Signals

Published on: January 13, 2022

2.2K
Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction
11:07

Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction

Published on: April 14, 2022

2.6K
Fabrication of the Composite Regenerative Peripheral Nerve Interface C-RPNI in the Adult Rat
10:35

Fabrication of the Composite Regenerative Peripheral Nerve Interface C-RPNI in the Adult Rat

Published on: February 25, 2020

8.5K

Area of Science:

  • Biomedical Engineering
  • Neuroprosthetics
  • Surgical Innovation

Background:

  • Limb amputation presents challenges in restoring functional control and preventing secondary complications.
  • Existing prosthetic technologies often lack intuitive control and can lead to limb atrophy and sensory deficits.

Purpose of the Study:

  • To introduce and evaluate a novel agonist-antagonist myoneural interface for prosthetic limb control.
  • To assess the interface's efficacy in augmenting volitional control, preserving proprioception, and preventing limb atrophy.

Main Methods:

  • Development of a surgical construct creating an agonist-antagonist myoneural interface.
  • Implementation of a neural interfacing approach for prosthetic augmentation.
  • Evaluation of functional outcomes related to prosthetic control and limb preservation.

Main Results:

  • The agonist-antagonist myoneural interface demonstrated potential for enhanced volitional control of adapted prostheses.
  • The approach showed promise in preserving proprioception in amputees.
  • Preliminary findings suggest the interface may help prevent limb atrophy.

Conclusions:

  • The agonist-antagonist myoneural interface represents a significant advancement in neuroprosthetic technology.
  • This novel approach offers a promising solution for improving outcomes in individuals with limb amputation.
  • Further research is warranted to fully elucidate the long-term benefits and applications.